These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 30561809)

  • 81. 17β-estradiol improves the efficacy of exploited autologous bone marrow-derived mesenchymal stem cells in non-union radial defect healing: A rabbit model.
    Zamani Mazdeh D; Mirshokraei P; Emami M; Mirshahi A; Karimi I
    Res Vet Sci; 2018 Jun; 118():11-18. PubMed ID: 29334646
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Dissimilar differentiation of mesenchymal stem cells from bone marrow, umbilical cord blood, and adipose tissue.
    Rebelatto CK; Aguiar AM; Moretão MP; Senegaglia AC; Hansen P; Barchiki F; Oliveira J; Martins J; Kuligovski C; Mansur F; Christofis A; Amaral VF; Brofman PS; Goldenberg S; Nakao LS; Correa A
    Exp Biol Med (Maywood); 2008 Jul; 233(7):901-13. PubMed ID: 18445775
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Equine peripheral blood-derived progenitors in comparison to bone marrow-derived mesenchymal stem cells.
    Koerner J; Nesic D; Romero JD; Brehm W; Mainil-Varlet P; Grogan SP
    Stem Cells; 2006 Jun; 24(6):1613-9. PubMed ID: 16769763
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Downregulation of Melanoma Cell Adhesion Molecule (MCAM/CD146) Accelerates Cellular Senescence in Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells.
    Jin HJ; Kwon JH; Kim M; Bae YK; Choi SJ; Oh W; Yang YS; Jeon HB
    Stem Cells Transl Med; 2016 Apr; 5(4):427-39. PubMed ID: 26941359
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Procoagulant activity of human mesenchymal stem cells.
    Christy BA; Herzig MC; Montgomery RK; Delavan C; Bynum JA; Reddoch KM; Cap AP
    J Trauma Acute Care Surg; 2017 Jul; 83(1 Suppl 1):S164-S169. PubMed ID: 28628602
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Therapeutic Potential of Mesenchymal Stem Cell-Derived Exosomes in the Treatment of Eye Diseases.
    Harrell CR; Simovic Markovic B; Fellabaum C; Arsenijevic A; Djonov V; Arsenijevic N; Volarevic V
    Adv Exp Med Biol; 2018; 1089():47-57. PubMed ID: 29774506
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Serum-mediated Activation of Bone Marrow-derived Mesenchymal Stem Cells in Ischemic Stroke Patients: A Novel Preconditioning Method.
    Moon GJ; Cho YH; Kim DH; Sung JH; Son JP; Kim S; Cha JM; Bang OY
    Cell Transplant; 2018 Mar; 27(3):485-500. PubMed ID: 29774769
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Human pluripotent stem cell (PSC)-derived mesenchymal stem cells (MSCs) show potent neurogenic capacity which is enhanced with cytoskeletal rearrangement.
    Peng KY; Lee YW; Hsu PJ; Wang HH; Wang Y; Liou JY; Hsu SH; Wu KK; Yen BL
    Oncotarget; 2016 Jul; 7(28):43949-43959. PubMed ID: 27304057
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Mitochondria in mesenchymal stem cell biology and cell therapy: From cellular differentiation to mitochondrial transfer.
    Hsu YC; Wu YT; Yu TH; Wei YH
    Semin Cell Dev Biol; 2016 Apr; 52():119-31. PubMed ID: 26868759
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Development and characterization of novel clinical grade neonatal porcine bone marrow-derived mesenchymal stem cells.
    Nishimura M; Nguyen L; Watanabe N; Fujita Y; Sawamoto O; Matsumoto S
    Xenotransplantation; 2019 May; 26(3):e12501. PubMed ID: 30768802
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Effects of mesenchymal stem cells from human induced pluripotent stem cells on differentiation, maturation, and function of dendritic cells.
    Gao WX; Sun YQ; Shi J; Li CL; Fang SB; Wang D; Deng XQ; Wen W; Fu QL
    Stem Cell Res Ther; 2017 Mar; 8(1):48. PubMed ID: 28253916
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Current Research and Use of Mesenchymal Stem Cells in the Therapy of Autoimmune Diseases.
    Chen Y; Yu Q; Hu Y; Shi Y
    Curr Stem Cell Res Ther; 2019; 14(7):579-582. PubMed ID: 31729289
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Tracking fusion of human mesenchymal stem cells after transplantation to the heart.
    Freeman BT; Kouris NA; Ogle BM
    Stem Cells Transl Med; 2015 Jun; 4(6):685-94. PubMed ID: 25848121
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Molecular targeting regulation of proliferation and differentiation of the bone marrow-derived mesenchymal stem cells or mesenchymal stromal cells.
    Chen BY; Wang X; Chen LW; Luo ZJ
    Curr Drug Targets; 2012 Apr; 13(4):561-71. PubMed ID: 22443584
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Pluripotent Stem Cells as a Robust Source of Mesenchymal Stem Cells.
    Luzzani CD; Miriuka SG
    Stem Cell Rev Rep; 2017 Feb; 13(1):68-78. PubMed ID: 27815690
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Human Wharton's jelly mesenchymal stem cells: properties, isolation and clinical applications.
    Borys-Wójcik S; Brązert M; Jankowski M; Ożegowska K; Chermuła B; Piotrowska-Kempisty H; Bukowska D; Antosik P; Pawelczyk L; Nowicki M; Jeseta M; Kempisty B
    J Biol Regul Homeost Agents; 2019 Jan-Feb,; 33(1):119-123. PubMed ID: 30729769
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Cell adhesion and long-term survival of transplanted mesenchymal stem cells: a prerequisite for cell therapy.
    Lee S; Choi E; Cha MJ; Hwang KC
    Oxid Med Cell Longev; 2015; 2015():632902. PubMed ID: 25722795
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Potential therapeutic applications of mesenchymal stem cells in the oral and maxillofacial tissues.
    Al-Hamad KA; Shanab HG; Gaballah OM; Moawad AAR; Alayfan G; Alshebel A; Alqahtani AMA; Almaziad M
    Eur Rev Med Pharmacol Sci; 2023 Jul; 27(13):6006-6017. PubMed ID: 37458639
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Stem cell therapies for chronic obstructive pulmonary disease: mesenchymal stem cells as a promising treatment option.
    Lai S; Guo Z
    Stem Cell Res Ther; 2024 Sep; 15(1):312. PubMed ID: 39300523
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Genetically Modified Mesenchymal Stem Cells: The Next Generation of Stem Cell-Based Therapy for TBI.
    Shahror RA; Wu CC; Chiang YH; Chen KY
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32516998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.